Affy Says It Will Clear Up Convertible Note Default When It Files Delayed Earnings Report Next Month | GenomeWeb
NEW YORK (GenomeWeb News) – Affymetrix said yesterday it will avoid having to pay certain convertible note holders earlier than expected once it files its delayed second-quarter earnings report with the Securities and Exchange Commission next month.
 
Affy yesterday said that on Aug. 17 it received a notice from certain investors saying it had defaulted on the terms of its $120 million convertible note program because it had delayed filing its financial statements with the SEC for the three months ended June 30.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.